CEO: Dr. Christian Martin Itin Ph.D.

IPO: 2018-06-22

Headquarters: US

Employees: 399

Homepage

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Gossamer Bio Inc

Sarepta Therapeutics Inc

Albireo Pharma Inc

Madrigal Pharmaceuticals Inc

Mirati Therapeutics Inc